-
公开(公告)号:CA2514145A1
公开(公告)日:2004-08-05
申请号:CA2514145
申请日:2004-01-20
Applicant: UCB FARCHIM SA
Inventor: CAVOY EMILE , BOUVY DIDIER , ATES CELAL
IPC: C07D201/00 , C07D271/06 , C07D271/07 , C07D295/15 , C07D295/14 , A61K31/495
Abstract: The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
-
公开(公告)号:AU2004205494A1
公开(公告)日:2004-08-05
申请号:AU2004205494
申请日:2004-01-20
Applicant: UCB FARCHIM SA
Inventor: ATES CELAL , CAVOY EMILE , BOUVY DIDIER
IPC: C07D201/00 , C07D271/06 , C07D271/07 , C07D295/15 , C07D295/14
Abstract: The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
-
公开(公告)号:PL357097A1
公开(公告)日:2004-07-12
申请号:PL35709701
申请日:2001-02-01
Applicant: PROCTER & GAMBLE
Inventor: CAZER FREDRICK DANA , PERRY GREGORY EUGENE , BILLINGS DENNIS MICHAEL , REDMAN-FUREY NANCY LEE
IPC: A61K31/663 , A61K31/675 , A61P3/14 , A61P19/00 , A61P19/02 , A61P19/08 , A61P19/10 , A61P25/00 , A61P29/00 , C07D201/00 , C07F9/58
Abstract: The present invention discloses 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium hemipentahydrate and monohydrate, methods of preparing the hemipentahydrate or monohydrate through control of the nucleation temperature and rate of crystallization and pharmaceutical compositions containing one or both of the hydrate forms.
-
224.
公开(公告)号:AU2003297647A1
公开(公告)日:2004-06-30
申请号:AU2003297647
申请日:2003-12-04
Applicant: SQUIBB BRISTOL MYERS CO
Inventor: VU TRUC CHI , BRZOZOWSKI DAVID B , FOX RITA , GODFREY JOLLIE DUAINE JR , HANSON RONALD L , KOLOTUCHIN SERGEI V , MAZZULLO JOHN A JR , PATEL RAMESH N , WANG JIANJI , WONG KWOK , YU JURONG , ZHU JASON , MAGNIN DAVID R , AUGERI DAVID J , HAMANN LAWRENCE G
IPC: A61K31/403 , A61K31/435 , C07C62/06 , C07C69/00 , C07C69/716 , C07C229/28 , C07C271/22 , C07D20060101 , C07D201/00 , C07D207/22 , C07D207/277 , C07D209/02 , C07D209/52 , C07D221/02
Abstract: Methods and compounds for production of cycloproyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV are provided.
-
公开(公告)号:AT263148T
公开(公告)日:2004-04-15
申请号:AT00987278
申请日:2000-11-21
Applicant: MORPHOCHEM AG
Inventor: MUELLER THOMAS , ANSORGE MARKUS
IPC: A61P31/04 , A61P31/10 , C07D201/00 , C07D231/06 , C07D417/12 , C07D417/14 , C07D471/04
Abstract: The invention relates to a process for the preparation of heterocycles, characterised in that the following components:i) a propargyl derivative of the general structural formula Ia wherein Het is an optionally substituted hetero atom and A is a substituted or unsubstituted aromatic entity, a substituted or unsubstituted aromatic heterocycle, a substituted or unsubstituted vinyl arene and/or a derivative thereof, an olefin, an alkyne, an acceptor group or a nitrile;(ii) a compound of the general structural formula II,wherein B is an electron-deficient substituted or unsubstituted aromatic entity with or without an acceptor group, an electron-deficient substituted or unsubstituted heteroaromatic entity with or without an acceptor group, an electron-deficient olefin and/or alkyne, a metal complex, and X is a leaving group;(iii) a nucleophile of the general structural formula III,wherein Y and/or Z, each independently of the other, is an amino group, thio group (mercapto group), seleno group, telluro group, hydroxy group (alcohol group), imido group, carbonyl group, thiocarbonyl group, selenocarbonyl group, tellurocarbonyl group; C is a substituted or unsubstituted C atom, a substituted or unsubstituted or annelated CC double bond or single bond and n=0-10, preferably 1-5, preferably are reacted in a one-pot reaction by cyclocondensation to form 4- to 10-membered, preferably 5- to 7-membered, heterocyclic, aromatic or non-aromatic ring systems.
-
公开(公告)号:NZ519966A
公开(公告)日:2004-03-26
申请号:NZ51996601
申请日:2001-02-01
Applicant: PROCTER & GAMBLE
Inventor: CAZER FREDERICK DANA , PERRY GREGORY EUGENE , BILLINGS DENNIS MICHAEL , REDMAN-FUREY NANCY LEE
IPC: A61K31/663 , A61K31/675 , A61P3/14 , A61P19/00 , A61P19/02 , A61P19/08 , A61P19/10 , A61P25/00 , A61P29/00 , C07D201/00 , C07F9/58
Abstract: A process for selectively producing 3-pyridyl-1- hydroxyethlidene-1, 1-bisphosphonic acid sodium hemipentahydrate and monohydrate. The steps involved in producing these compounds include, providing an aqueous solution of 3-pyridyl-1-hydroxyethlidene-1,1 bisphosphonic acid sodium, heating the aqueous solution to a temperature from about 45 C to about 75 C and adding a solvent (from the group of alcohols, esters, ethers, ketones, amides and nitriles) to the aqueous solution. An optional step of cooling the aqueous solution is also included. A pharmaceutical composition comprising 3-pyridyl-1- hydroxyethlidene-1,1-bisphosphonic acid sodium is also claimed when it is produced by the above process and when it comprises 50-100% hemipentahydrate and about 50-0% monohydrate.
-
公开(公告)号:ES2188891T3
公开(公告)日:2003-07-01
申请号:ES97902722
申请日:1997-02-05
Inventor: GUIT RUDOLF PHILIPPUS MARIA , FRENTZEN YVONNE HELENE
IPC: C07D201/00 , C07D201/08 , C07D201/16 , C07D223/10
Abstract: Process to separate epsi-caprolactam from an aqueous mixture containing epsi-caprolactam and at least 0.5 wt % oligomers, wherein the separation is performed by extraction using an organic extraction agent. The aqueous mixture may be obtained in a process to prepare epsi-caprolactam starting from 6-aminocapronitrile or in a process to prepare epsi-caprolactam starting from 6-aminocaproic acid.
-
公开(公告)号:AT239702T
公开(公告)日:2003-05-15
申请号:AT99910210
申请日:1999-02-05
Applicant: DUPHAR INT RES
Inventor: DEN HARTOG JACOBUS A J , VISSER GERBEN M , VAN STEEN BARTHOLOMEUS J , TULP MARTINUS T M , RONKEN ERIC , KRUSE CORNELIS G
IPC: A61K31/4709 , A61K31/496 , A61P25/00 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D201/00 , C07D215/38 , C07D401/12 , C07D405/12
Abstract: The present invention relates to a group of novel 2-aminoquinoline derivatives which are potent and selective agonists of the dopamine D4-receptor. The compounds have general formula (I) wherein (R1)n represents 1 or 2 substituents, which can be the same or different, from the group C1-3-alkyl or alkoxy, halogen, trifluoromethyl, nitro, amino, and mono- or dialkyl (C1-2)amino, or two groups R1 at adjacent carbon atoms together with the benzene ring may form the benzdioxane group or benzofuran group, X represents nitrogen or carbon, and the dotted line may represent a double bond, (R2)p represents 0, 1 or 2 substituents, which can be the same or different, from the group methyl and ethyl, or (R2)p is a methylene bridge or ethylene bridge, R3 is hydrogen or methyl, and (R)m represents 0, 1, or 2 substituents, which can be the same or different and can be located at all available positions of the quinolyl group, from the group C1-3-alkyl or alkoxy, halogen, trifluoromethyl, nitro, amino, and mono- or dialkyl (C1-2)amino, on the understanding that R1 cannot represent o-OCH3 when X is nitrogen, (R2)p and R3 are hydrogen, m is 0 and n is 1
-
公开(公告)号:DK1187824T3
公开(公告)日:2003-03-10
申请号:DK00915232
申请日:2000-03-29
Applicant: PF MEDICAMENT
Inventor: VACHER BERNARD , CUISIAT STEPHANE , KOEK WOUTER
IPC: A61P25/00 , A61P25/16 , A61P25/18 , A61P25/30 , C07D333/20 , A61K31/38 , C07D201/00
Abstract: The present invention relates to novel [(2-substituted-5-[3-thienyl])-benzyl]-[2-([2-isopropoxy-5-fluoro]-phenoxy)-ethyl]-amine derivatives having formula (1) and the use thereof as medicaments, especially anti-psychotic medicaments.
-
公开(公告)号:MXPA02007417A
公开(公告)日:2002-12-09
申请号:MXPA02007417
申请日:2001-02-01
Applicant: PROCTER & GAMBLE
Inventor: CAZER FREDRICK DANA
IPC: A61K31/663 , A61K31/675 , A61P3/14 , A61P19/00 , A61P19/02 , A61P19/08 , A61P19/10 , A61P25/00 , A61P29/00 , C07D201/00 , C07F9/58
Abstract: La presente invencion revela hemipentahidrato y monohidrato de acido 3-piridil-1-hidroxi- etiliden-1,1-bisfosfonico sodio, metodos de preparar el hemipentahidrato o monohidrato a traves del control de la temperatura de nucleacion y la velocidad de cristalizacion, y composiciones farmaceuticas que contienen una o ambas formas del hidrato.
-
-
-
-
-
-
-
-
-